Alterations in the levels of adhesion and motility of cells are critical events in the development of metastasis. Cyclin D1 (CycD1) is one of the most frequently amplified oncogenes in many types of cancers and it is also associated with the development of metastasis. Despite this, we still do not know which are all the relevant pathways by which CycD1 induces oncogenic processes. CycD1 functions can be either dependent or independent of the cyclin-dependent kinase Cdk4, and they affect several cellular aspects such as proliferation, cell attachment and migration. In this work, we reveal a novel function of CycD1 that fosters our understanding of the oncogenic potential of CycD1. We show that CycD1 binds to the small GTPases Ral A and B, which are involved, through exocyst regulation, in the progression of metastatic cancers, inducing anchorage-independent growth and cell survival of transformed cells. We show that CycD1 binds active Ral complexes and the exocyst protein Sec6, and co-localizes with Ral GTPases in trans-Golgi and exocyst-rich regions. We have also observed that CycD1-Cdk4 phosphorylates the Ral GEF Rgl2 'in vitro' and that CycD1-Cdk4 activity stimulates accumulation of the Ral GTP active forms. In accordance with this, our data suggest that CycD1-Cdk4 enhances cell detachment and motility in collaboration with Ral GTPases. This new function may help explain the contribution of CycD1 to tumor spreading.
Introduction
Cyclin D1 (CycD1) belongs to the family of D-type cyclins, which also includes cyclin D2 and cyclin D3 (Matsushime et al., 1991; Xiong et al., 1991) . D-cyclins are regulatory subunits of the cyclin-dependent kinases Cdk4 and Cdk6 that are involved in G1-S transition of the cell cycle and are essential for development and viability in mammals Roberts, 1999, 2004; Kozar et al., 2004; Bienvenu et al., 2010) . D-cyclins are also considered as key sensors communicating extracellular cues to cell growth and cell cycle machineries (Fu et al., 2004; Musgrove, 2006) . Through different signaling pathways, mitogenic signals induce transcription and translation of the CycD1 gene, increase stabilization of the protein, and promote binding of CycD1 to Cdk4 and the accumulation of CycD1-Cdk4 complexes in the cell nucleus (Klein and Assoian, 2008; Kim and Diehl, 2009) . Once in the nucleus, CycD1-Cdk4 complexes activate the E2F-type transcriptional regulators by phosphorylation and inhibition of the transcriptional repressor pRB. E2F induces transcription of cyclin E and Cdk2, promoting the initiation of S phase (Sherr and Roberts, 1999) . Additionally, CycD1-Cdk4 complexes exert a non-catalytic function by sequestration of Cdk inhibitors, including p27 and p21, which are inhibitors of the cyclin E-Cdk2 complexes.
Gene amplification and overexpression of CycD1 is a common event in several types of human tumors (Beroukhim et al., 2010) . Targeted overexpression of CycD1 in the mammary gland is sufficient for the induction of mammary carcinoma (Wang et al., 1994) . Additionally, expression of high levels of an alternative splicing variant that finally alters the amino-acid sequence of the C terminus, CycD1b, is able to induce transformation in NIH-3T3 cells (Lu et al., 2003; Solomon et al., 2003) . In accordance with the importance of CycD1 in cellular transformation, CycD1-deficient mice are resistant to the development of apc-induced gastrointestinal tumors and ras-induced mammary tumors (Yu et al., 2001; Hulit et al., 2004) . The pathological function of CycD1 had initially been related only to its ability to induce cell proliferation in a Cdk4-dependent manner. However, tumors overexpressing CycD1 exhibit relatively normal levels of proliferation and expression of EF2 targets, in contrast to those tumors caused by inactivation of pRB or overexpression of cyclin E (Ewen and Lamb, 2004) . Also, the potent cellular transformation effects induced by CycD1b do not correlate with augmented levels of pRB phosphorylation (Solomon et al., 2003) . Additional studies have demonstrated that CycD1 also functions as a transcriptional modulator in a Cdk4-independent manner, underlining the importance of Cdk-independent mechanisms in CycD1-mediated oncogenesis (Coqueret, 2002; Ewen and Lamb, 2004) .
Although high levels of nuclear CycD1-Cdk4 activity are important for tumorigenesis (Kim and Diehl, 2009 ), all these findings suggest that the oncogenic function of CycD1 is something more than the stimulation of E2F-dependent transcription.
In order to understand its pathological consequences, it is important to note that CycD1 has an important role in regulating cell adhesion and migration (Neumeister et al., 2003; Li et al., 2006a, b) . Thus, CycD1 induces cell motility by inhibiting the RhoA pathway and stabilizing p27. This function is dependent on Cdk4-associated kinase activity and independent of pRB. Recently, it has been demonstrated that there exists an association between the levels of CycD1-Cdk4 activity and invasiveness and metastasis development in MDA-MB-231 breast cancer cell lines (Zhong et al., 2010) . Previously, CycD1 overexpression had already been correlated with tumor metastasis (Drobnjak et al., 2000) . All these data strongly suggest that CycD1 may contribute to tumor spreading through the regulation of processes such as cell attachment and motility. Importantly, CycD1 is localized in membrane ruffles and interacts with Filamin A and other cytoskeleton proteins in MDA-MB-231 cell lines, suggesting the existence of cytoplasmatic events regulated by CycD1 (Zhong et al., 2010) . This possibility is not uncommon considering that the homologous partner of the CycD1-Cdk4 complex in yeast is also active in the cytoplasm, modulating the function of the Rho GTPase Rho1 and Cdc42 through phosphorylation of different GTPase regulators (Knaus et al., 2007; Kono et al., 2008) .
In the present work, we show the interaction of CycD1 with Ral A and B, two small GTPases that regulate exocyst assembly and participate in the control of cell attachment and migration (Rosse et al., 2006; Shi et al., 2006; Spiczka and Yeaman, 2008) . Ral A and B are activated in metastatic cancers through multiple mechanisms and induce anchorage-independent growth and cell survival of transformed cells (Bodemann and White, 2008) . Our experiments suggest that CycD1 collaborates with Ral GTPases in the regulation of cell adhesion and motility.
Results

CycD1 binds Ral A and B GTPases
In order to identify new partners of CycD1, full-length CycD1 was used as bait in a yeast two-hybrid screen with a mouse brain cDNA library. Among the clones isolated in the screen, we identified a clone harboring the C-terminus of the Ral-specific guanine nucleotide exchange factor Rlf (Rgl2 in humans) (Wolthuis et al., 1997) (not shown). To verify the yeast two-hybrid data, we demonstrated that HA-Rlf (aa396-778) co-immunoprecipitated with FLAG-CycD1 in HEK293T cells (Figure 1a) . Also, mouse Cdk4 expressed in immortalized mouse embryonic fibroblasts (MEFs) co-immunoprecipitated with FLAG-Rgl2 (Figure 1b) , revealing that the whole CycD1-Cdk4 complex could interact with this RalGEF. Interestingly, this co-immunoprecipitation was not detected in CycD1-deficient MEFs, indicating that the interaction between Cdk4 and Rgl2 probably requires CycD1 to bridge the ternary complex. Unfortunately, the interactions between CycD1 (or Cdk4) with Rgl2 were detected only under overexpression conditions. However, we were able to detect coimmunoprecipitation of endogenous CycD1 with the small GTPases RalA and HA-RalB (Figures 1c and d) . In the same pull-downs, we also observed co-immunoprecipitation of Cdk4. As a negative control, we performed the CycD1 pull-down in CycD1-deficient cells. Contrary to what happened with Rgl2, the interaction between RalA and CycD1 was not observed by two-hybrid analysis, probably because it may be indirect (not shown). All these findings suggest that CycD1 is present in a molecular entourage together with Ral pathway components.
CycD1 co-localizes with Ral A and B GTPases in trans-Golgi and exocyst-rich regions The Ral GTPases localize in membranes and also show a punctuate distribution in the cytoplasm (Lim et al., 2005) . However, the cellular distribution of CycD1 is variable depending on the cell cycle phase and growth stage of the cells (Diehl et al., 1998; Alao, 2007) . In order to co-localize CycD1 with Ral GTPases in membrane compartments, we assayed specific protocols of immunofluorescence with gentle permeabilization steps (Yeaman et al., 2001) . Under these conditions, CycD1 co-localized with RalA in primary MEFs (not shown) and in immortalized MEFs (Figure 2a) , showing a peripheral and juxtanuclear distribution in the cytoplasm, whereas many cells showed a very low nuclear signal of CycD1. Similarly, we also detected co-localization of CycD1 with RalB in immortalized MEFs (Figure 2b ). We used different anti-CycD1 antibodies and the specificity was established with CycD1-deficient fibroblasts (Figure 2c ). The specificity of RalA and B localization was tested by using MEFs infected with lentivirus harboring HA-RalA and HA-RalB constructs (Figures 2d and 4a) .
The interaction of Cdk4 with Rgl2 suggested that not only CycD1 but also the whole CycD1-Cdk4 complex was able to interact with Ral pathway components, and that the formation of a ternary complex may depend on CycD1 (see above, Figure 1b) . For this reason, we also tested the localization of Cdk4 under the same immunofluorescence conditions by using a monoclonal anti-Cdk4 antibody (Figure 3 ). We found that Cdk4 co-localized with CycD1 in cytoplasmic foci, but the presence of Cdk4 foci was greatly reduced in the absence of CycD1. These data are consistent with the previous immunoprecipitation results and attaches an important role to CycD1 in the interaction of Cdk4 with Ral components.
The CycD1 and Ral cytoplasmatic distribution is coincident with those reported for active Ral sites and exocyst proteins localized at specific sites in trans-Golgi or at the cell periphery in protrusive cell extensions (Spiczka and Yeaman, 2008) . In agreement with this, we observed that HA-RalB and CycD1 co-localized with the exocyst protein Sec6 in immortalized MEFs 
MEFs. (c) CycD1
À/À immortalized MEFs were analyzed with the same protocol and antibodies. Controls of secondary antibodies are also shown in c. In a, b and c images were acquired by confocal microscopy using an Â 60 objective (5 mm bar). (d) Co-localization of RalA (anti-HA 3F10, green) and CycD1 (DCS6 antibody, red) were analyzed in MEFs infected with 3HA-RalA. As a control, non-infected cells are shown. Images were acquired using an Â 40 objective (20 mm bar). Nuclei were stained with Hoescht (blue).
( Figures 4a and b) , and also that CycD1 co-localizes with the trans-Golgi marker TGN38 in juxtanuclear positions ( Figure 4c ). Moreover, Sec6 co-immunoprecipitated with CycD1 in MEF extracts ( Figure 1d ). These data suggest that CycD1 is localized together with the exocyst in active Ral sites. To delve deeper into the study of this possibility, we have analyzed the co-localization of CycD1 with b1-integrin. Integrins co-localize with exocyst components, and Ral activity is required for an efficient traffic and recycling of integrins (Spiczka and Yeaman, 2008) . In Figures 4d and e we show the co-localization of D1 with b1-integrin that exhibits a peripheral and juxtanuclear distribution in the cytoplasm of spread cells. This result reinforces the hypothesis that CycD1 is present in active Ral sites with exocyst components.
Cytoplasmatic co-localization between CycD1 and RalA is observed in different cell lines and processes We have also characterized the cytoplasmic localization of CycD1 in different epithelial cell lines. First, after a wound healing in a confluent layer of MDCK cells infected with HA-CycD1, CycD1 was localized in cytoplasmatic foci only in migrating cells (Figure 5a ). Second, MCF7 cells were seeded at low confluence and fixed after 1 h. In this condition we have observed co-localization of CycD1 and RalA, mainly distributed in a juxtanuclear dot per cell ( Figure 5b ). In all the cells analyzed, CycD1 and Ral A showed the same polarity as both are placed at the same side of the cell (not shown). Third, we analyzed CycD1 localization in a prostate tumor cell line with enhanced metastatic potential (Luo et al., 1997) . In these cells, we also observed co-localization of CycD1 with Ral A in cytoplasmic foci in normal culture conditions ( Figure 5c ). These results strongly associate the specific localization of CycD1 and RalA in foci with the regulation of cell attachment and motility, and also with the metastatic phenotype.
CycD1 modulates Ral GTPase activity
Ral GTPases regulate exocyst assembly, and the active forms of Ral, loaded with GTP, can directly bind to different subunits of the exocyst (Moskalenko et al., 2002) . Our localization data suggested that CycD1 was present with the exocyst in active Ral sites (see above). To determine whether CycD1 was able to interact with complexes containing active forms of Ral, we used a Ral-GTP pull-down assay with the GST-fused Ral binding domain of the RalBP1 protein (RalBP beads). Using NIH3T3 cell extracts, we detected endogenous Figure 3 Cdk4 co-localizes with CycD1 in cytoplasmatic foci of immortalized MEFs and the punctuate distribution of Cdk4 depends on the presence of CycD1. (a) Both CycD1 (polyclonal antibody, green) and Cdk4 (DCS35 antibody, red) co-localize in cytoplasmatic foci. Controls were done as in Figure 2c (not shown). Images were acquired by confocal microscopy using an Â 60 objective (5 mm bar). (b) By using the same low-permeabilization conditions and antibodies than in a, the localization of Cdk4 was compared in D1 À/À and D1 þ / þ MEFs. Images were acquired using an Â 40 objective (20 mm bar). Nuclei were stained with Hoescht (blue).
levels of CycD1 bound to RalBP beads ( Figure 6a ). In an independent experiment, HEK293T cells were transfected with HA-CycD1 and lysates were pulled down with RalBP beads (Figure 6b ). In both experiments we detected specific CycD1 binding with RalBP beads. These data indicate that CycD1 interacts with Ral-GTP and is present in complexes containing active Ral.
To analyze the functional relevance of the presence of CycD1 in active Ral sites, we checked the effects of the CycD1 expression on Ral GTPase activation (Figure 6c ). Expression of high levels of CycD1 in HEK293T cells induced the accumulation of Ral B active forms, which suggests that CycD1 has a positive role in the activation of Ral GTPases. Additionally, we sought to determine whether this function of CycD1 was dependent on the kinase activity of the CycD1-Cdk4 complex. For this reason, we analyzed the effects of the CycD1K112E allele that is unable to produce CycD1-Cdk4 active complexes (Day et al., 2009) . Overexpression of the K112E allele of CycD1 did not produce the accumulation of RalB active forms (Figure 6c ). These data support the idea that the CycD1-Cdk4 kinase activity is required to regulate Ral activation, which is consistent with the interaction between Rgl2 and Cdk4 (Figure 1b) , and the co-localization of CycD1 and Cdk4 in cytoplasmic foci (Figure 3 ) (see above). It is important to note that full-length HA-Rgl2 (not shown) Figure 4 CycD1 localizes in trans-Golgi and exocyst-rich regions in immortalized MEFs. (a) Co-localization of RalB (anti-HA 3F10, green) and Sec6 (9H5 antibody, red) was analyzed in MEFs infected with 3HA-RalB. As a control, non-infected cells are shown. Images were acquired using an Â 40 objective (20 mm bar). (b, c) CycD1 (polyclonal antibody, green) co-localizes with the exocyst protein Sec6 (9H5 antibody, red) and with the trans-Golgi marker TGN38 (2F7 antibody, red) in MEFs. Images were acquired by confocal microscopy using an Â 60 objective (5 mm bar). (d, e) CycD1 (polyclonal antibody, green) co-localizes with b1-integrin (P5D2 antibody, red) in spread MEFs. Images were acquired using an Â 40 objective (20 mm bar) in d and confocal microscopy using an Â 60 objective (20 mm bar) in e. Nuclei were stained with Hoescht (blue).
CycD1 and Ral collaborate in cell-motility control RMH Fernández et al co-immunoprecipitated with the FLAG-CycD1-K112E mutant protein in HEK293T cells. These data indicate that Cdk4-associated kinase activity is required for Ral stimulation but not for interaction of CycD1 with components of the Ral pathway. Our work suggests a substrate relationship between the D1/Cdk4 kinase complex and Ral pathway components. As Ral A and B GTPases do not show putative Cdkphosphorylation sites in their sequences, CycD1-Cdk4 might regulate Ral activity by acting on Ral regulators. In accordance with this, we have observed phosphorylation of Rgl2 by CycD1-Cdk4 'in vitro' (Figure 6d ). This phosphorylation may be specific, as it is highly reduced in the presence of the Cdk inhibitor flavopiridol. A similar behavior was observed with pRB as a substrate although the band intensity suggests that pRB is a better Cdk4 substrate or has more target sites. The Rgl2 phosphorylation is consistent with the substrate relationship suggested by our work, and opens the possibility that CycD1-Cdk4 regulates the Ral activity through the activation of Rgl2 by phosphorylation.
CycD1 and Ral GTPases collaborate in the regulation of cell motility
To investigate the collaboration of CycD1 and Ral in the regulation of cell attachment and motility dynamics, we first analyzed the effects of the stimulation of Ral activity on the motility of CycD1-deficient MEFs. These cells show increased cell adhesion and reduced motility rates (Li et al., 2006a) . Considering that CycD1 may have a positive role in the control of Ral activity, we expected that stimulation of Ral could restore the defects of CycD1-deficient cells. Thus, to stimulate Ral activity we transfected the hyperactive allele Rgl2-CAAX in CycD1-deficient cells and analyzed the rates of cell motility. Stimulation of Ral activity enhanced the motility of CycD1-deficient cells, restoring wild-type behavior (Figures 7a and b) . These data suggest that CycD1 and the Ral pathway are functionally interrelated in the control of cell motility. In a different approach, we have analyzed the effects of the stimulation of Ral pathway in the attachment efficiency of CycD1-deficient MEFs. In these cells and by using lentiviral infection, we have observed that addition of the hyperactive allele Rgl2-CAAX promoted a lack in the efficiency of attachment in fibronectin-coated plates restoring wild-type conditions (Figure 7c ). The cdkactivity-defective mutant, CycD1-K112E allele, did not reduce the efficiency of attachment in CycD1-deficient cells, which is consistent with previous data (Li et al., 2006a) and with its incompetence to stimulate Ral activity (Figure 6c ). We have also tested the attachment abilities by measuring the efficiency of spreading in fibronectin-coated plates. D1 À/À MEFs were co-transfected with green fluorescent protein (GFP) plus empty expression vectors, or with GFP plus CycD1 or Rgl2-CAAX or RalBS28N expression vectors. Stimulation of Ral activity produced a reduction in the number of spread CycD1-deficient cells (Figure 7d ). In D1 þ / þ MEFs the stimulation of Ral activity did not produce any variation in the spreading efficiency. Interestingly, expression of CycD1 in CycD1-deficient MEFs only reduced spread-cell rates in the presence of an active Ral pathway (Figure 7e) . Thus, our data suggest that CycD1 controls cell attachment, at least in part, through the modulation of the Ral activity.
Discussion
The migration of tumor cells towards blood vessels is the initial step towards undergoing metastasis (Sahai, 2007) . Thus, to better understand the initiation of metastasis, it is important to study in deep the mechanisms that regulate cell detachment and movement (Condeelis and Segall, 2003; Friedl and Wolf, 2003) . In this work, we initially describe a novel mechanism controlling cell attachment and motility that connects two potent oncogenic factors, CycD1 and RalGTPases. We show that CycD1 binds to the GTPases Ral A and B and modulates Ral activity in a Cdk4-dependent manner. Our data suggest that the recruitment of Cdk4 around the Ral pathway is dependent on CycD1. Ral-GTPases bind to different components of the exocyst and control cell motility through diverse mechanisms (Bodemann and White, 2008) . For instance, Ral-coupled exocyst activity promotes cell movement through integrin recycling and also through the targeting of exocyst to focal adhesion complexes (Spiczka and Yeaman, 2008) . Notably, we have also detected binding and co-localization of CycD1 with Sec6, indicating that CycD1 is present in exocyst-rich regions. This is reinforced by our observation that CycD1 co-localizes with b1-integrin distribution in the cytoplasm of spread cells. Thus, we propose that CycD1-Cdk4 activity locally enhances Ral stimulation to allow proper assembly of the exocyst and integrin recycling, which in turn would promote motility. In accordance with this, we have observed that stimulation of Ral activity subverts cell-motility and detachment deficiencies caused by the absence of CycD1. In any event, we cannot exclude that CycD1-Cdk4 could also regulate cell attachment and motility directly through the exocyst or other adhesion regulators. In agreement with our data, Ral B and a Clathrin subunit have been selected as CycD1 partners in a genetic-proteomic screen (Bienvenu et al., 2010) . Also, it has been demonstrated that CycD1 is found in cell ruffles and binds Filamin A, a component of the cytoskeleton and focal adhesion complexes (Zhong et al., 2010) . Interestingly, Filamin A interacts and is regulated by Ral A, providing another possible CycD1 and Ral collaborate in cell-motility control RMH Fernández et al nexus between CycD1, Ral A and the regulation of cell attachment (Ohta et al., 1999) . Our work underlines the significance of regulating Ral activity by CycD1-Cdk4 in the control of cell-motility dynamics. In which way does CycD1-Cdk4 regulate Ral activity? As Ral activity is controlled by different mechanisms, this fact opens multiple possibilities regarding the target(s) of CycD1-Cdk4. Our in vitro assays demonstrated that CycD1-Cdk4 complex is able to phosphorylate the Ral GEF Rgl2. This is consistent with the interaction of CycD1 and Rgl2 in two-hybrid analysis, suggesting the possibility of a direct interaction. Whether Rgl2 is an 'in vivo' substrate of CycD1-Cdk4, the interaction could be very transitory and for that reason may be difficult to detect under endogenous conditions. These data open the possibility that CycD1-Cdk4 regulates Ral activity through the activation of Rgl2 by phosphorylation. However, we cannot exclude the participation of other cell cycle and Ral regulators in the control of Ral activity. For example, the cyclindependent kinase inhibitor protein p27 is required for CycD1-mediated modulation of Rho activity (Li et al., 2006b) . Future work will be required to characterize the molecular mechanism connecting CycD1 to RalGTPase activity.
The normal and pathological functions of CycD1 are largely associated to its nuclear localization (Kim and Diehl, 2009; Bienvenu et al., 2010) . We think that this nuclear function is compatible with the presence of cytoplasmic CycD1-Cdk4 complexes that would play additional but relevant roles in oncogenesis, such as the regulation of cell motility. Our data and other recent evidences (Zhong et al., 2010) argue in favor of this option. What would be the importance of cytoplasmic CycD1-Cdk4 in normal and pathological circumstances? On the one hand, our hypothesis is that changes in the levels of cytoplasmic CycD1 could be critical to coordinate cell proliferation, migration and differentiation under normal circumstances. For instance, in brain development, neural progenitors have to inhibit proliferation, detach and migrate to upper layers in order to differentiate in the brain cortex (Kriegstein and Alvarez-Buylla, 2009 ). In agreement with our idea, CycD1 is present in the cytoplasm during neuronal MEFs were infected with different lentiviral vectors as indicated. Cells were seeded in serum-free medium in a 96-well plate coated with 10 mg/ml fibronectin. After 30 min, plates were washed two times with temperate phosphate-buffered saline, fixed and stained with crystal violet, and the absorbance was read at 590 nm (A590 nm). The experiment was done in triplicate. Mean values and confidence limits (a ¼ 0.05) are plotted. (d, e) D1 À/À and D1 þ / þ MEFs were co-transfected with GFP and different expression vectors as indicated. Forty-eight hours after transfection, cells were trypsinized and seeded in serum-free medium in 35-mm well plates coated with 10 mg/ml fibronectin. Forty-five (d) and thirty (e) minutes later, the proportion of spread green cells was determined for each condition. The experiment was independently repeated two times. Mean values and confidence limits (a ¼ 0.05; nX150) are plotted. differentiation (Sumrejkanchanakij et al., 2003) and it is required for neurite development (Marampon et al., 2008) . Interestingly, Ral activity is also needed for neuritogenesis, making likely the collaboration with CycD1 in this process (Lalli, 2009 ). On the other hand, under anomalous situations our work insinuates that spatial regulation of CycD1 during tumor progression could be relevant to acquire spreading phenotype. Our hypothesis considers the connection between CycD1 and Ral as functionally normal, and in tumorigenic cells the increase in local expression of CycD1 in the cytoplasm (perhaps due to overexpression) could imbalance Ralrelated functions, thus promoting tumor spreading and metastasis. The dynamics of tumor growth are highly complicated and transformed cell populations show numerous changes. A partial increment of the CycD1-Cdk4 complexes in the cytoplasm could simultaneously promote a stimulation of Ral and a decrease in Rho activities, promoting cell motility and tumor spreading. In accordance with this, CycD1 is present in the cytoplasm of transformed cells (Alao et al., 2006; Zhong et al., 2010) and is co-localizing with RalA (this paper). Thus, the importance of CycD1 as an oncogen would not depend on a single function but, on the contrary, the ability of this cyclin to control different and critical cellular mechanisms would be the cause of its outstanding oncogenic potential.
Materials and methods
Cell culture, transfections and lentiviral infections NIH3T3, HEK293T, MCF7 and MDCK cells were obtained from the American Type Culture Collection. D1
À/À and D1
immortalized MEFs and R3327-5 0 rat tumor cells were kindly provided by P Sicinski and M Hendrix, respectively. Primary MEFs were prepared by standard procedures. Cells were maintained at 37 1C in a 5% CO 2 incubator and grown in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum and 100 mg/ml penicillin/streptomycin and 2 mM glutamine. Migrative MDCK cells were obtained by wound healing. Transient transfection of vectors was performed with Lipofectamine 2000 (Invitrogen, Barcelona, CAT, Spain) according to the manufacturer's instructions. For lentivirus production, HEK293T cells were transfected with lentiviral expression vector, envelope plasmid pVSV.G and packaging plasmid pHR 0 82DR at a ratio of 2:1:1, and cultured as described above.
Expression vectors
Human CycD1 (a gift from N Agell), Rgl2 (IMAGE ID 5585507), human RalB (IMAGE ID 3880116) and human RalA (IMAGE ID 5495399) cDNAs were used to obtain N-terminal fusions to three copies of the FLAG or HA epitopes under the CMV promoter in pcDNA3 (Invitrogen), or under the UBI or CMV promoter in a lentiviral vector derived from pDSL (Invitrogen) after removal of the GFP transcriptional unit. PCR-mediated site-directed mutagenesis standard procedures were used to obtain the point mutation K112E in CycD1. The same method was used to obtain the insertion of the CAAX signal (aa179-189 C-terminal end of Kras) in the full Rgl2. The 3HA-Rlf (aa396-777) was cloned from pACT2 to a pcDNA3 derivative. Details of all constructs are available upon request. The dominant-negative allele RalBS28N was obtained from Addgene (CJ Der). Plasmid pMmCdk4 was obtained from MRC.
Immunoprecipitation and immunoblotting
Immunoprecipitation analysis of endogenous CycD1 was carried out in immortalized MEFs. Three 100 mm tissue culture plates of these cells were used for each immunoprecipitation sample. Briefly, cleared cell extracts in lysis buffer (50 mM Tris-HCl pH 8, 150 mM NaCl, 1% Triton 100 Â , 2 mM MgCl 2 , 2 mM dithiothreitol (DTT), and protease and phosphatase inhibitors) were immunoprecipitated with rabbit polyclonal antibodies against CycD1 (06-137, Upstate, Lake Placid, NY, USA) or FLAG (F7425, Sigma, St Louis, MO, USA) as dummy, and Protein A linked to magnetic beads (Dynabeads, Invitrogen). For immunoprecipitation of FLAGtagged proteins in transfected HEK293T cells, one 100-mm plate was used. In this case, lysis buffer contained 10 mM TrisHCl pH 8, 150 mM NaCl, 0.1% Tween 20, 0.5 mM EDTA, 0.5 mM DTT, and protease and phosphatase inhibitors, and cleared extracts were immunoprecipitated with aFLAG agarose (M2, Sigma). Protein samples were resolved by SDS-PAGE, transferred to polyvinylidene fluoride membranes (Millipore, Bedford, MA, USA), and analyzed by immunoblotting. Appropriate peroxidase-linked secondary antibodies (GE Healthcare UK Ltd, Little Chalfont, Buckinghamshire, UK) were detected using the chemiluminescent HRP substrate Immobilon Western (Millipore). Chemiluminescence originated from western blots was recorded with the aid of a CCD-based camera (Lumimager, Roche Diagnostics, Sant Cugat del Valle`s, CAT, Spain).
Immunofluorescence Cells were quickly washed in phosphate-buffered saline and fixed in 4% paraformaldehyde for 15 min at room temperature. Fixed MEFs and R3327-5 0 A cells were permeabilized with 0.02% Tween and blocked with 5% bovine serum albumin. MDCK cells were blocked and permeabilized with 0.2% Tween in 5% non-fat milk for 30 min. Primary antibodies were combined with adequate Alexa488 and/or Alexa594-labeled secondary antibodies (Molecular Probes, Leiden, Netherlands) in phosphate-buffered saline with 0.5% non-fat milk or bovine serum albumin, to detect tagged or endogenous proteins by immunofluorescence. Nuclei were stained with Hoechst (Sigma). Images were acquired using an Â 40 objective in an Olympus IX71 inverted microscope (Olympus, Barcelona, CAT, Spain). Confocal images were acquired in an Olympus FV500 confocal system using an Â 60 objective on an Olympus IX81 inverted microscope.
Antibodies
The antibodies used were as follows: HA (monoclonal 12CA5, our own stocks; rat monoclonal 3F10, Roche), FLAG (monoclonal M2, Sigma), Cdk4 (polyclonal sc-260, Santa Cruz Biotechnology, Santa Cruz, CA, USA; monoclonal DCS-35, Abcam, Cambridge, UK), Sec6 (monoclonal 9H5, Abcam), RalA (monoclonal 610221, BD Biosciences, Erembodegem, Belgium), CycD1 (polyclonal 06-137, Upstate; monoclonal DCS-6, BD Biosciences), RalB (polyclonal sc-1531, Santa Cruz Biotechnology), TGN38 (monoclonal 2F7.1, Abcam) and b1-integrin (monoclonal P5D2, Abcam).
Ral pull-down assay
The Ral activation was analyzed by measuring the GTP-bound form of Ral (van Triest et al., 2001) . The assays were performed by using RalBP1 agarose (Upstate, cat# 14-415) according to the manufacturer's instructions. Cell lysates were obtained from a 100-mm plate from transfected HEK293T cells. The lysis buffer used was 50 mM Tris pH 7.5, 200 mM NaCl, 2.5 mM MgCl 2 , 2.5 mM DTT, 1% Triton, and protease and phosphatase inhibitors. In all, 0.6 ml of cell lysate was incubated with 10 mg of RalBP1 beads for 30 min at 4 1C and, after several washes, agarose beads were resuspended in 2 Â Laemmli buffer. Samples were separated by SDS-PAGE, transferred to polyvinylidene fluoride membranes and immunoblotted. As shown in Figures 5a and b three 100-mm plates were used for each individual pull-down, and cell lysates were split into two halves and passed through either RalBP or GST beads as a negative control.
Kinase assay
The kinase reaction was done in 20 ml of kinase buffer (50 mM Tris-HCl pH 7.5, 10 mM MgCl 2 , 0.5 mM DTT, 1 mM EGTA and 2.5 mM b-glycerophosphate) containing 0.2 mg substrate (either Rgl2 or pRB), 1.5 ml of active D1/Cdk4 complex purified from baculovirus (Sigma C0620), 10 mM ATP, 7 mCi of g-32 P-ATP (Perkin-Elmer, Boston, MA, USA; 3000 Ci/mmol) and either DMSO or 5 mM of Cdk inhibitor flavopiridol (Santa Cruz Biotechnology, sc-202157) as negative control. The kinase mixture was incubated for 20 min at 30 1C, and finally the samples were boiled in 2 Â Laemmli buffer and separated by electrophoresis. Phosphorilated proteins were visualized by autoradiography of the dried slab gels.
For preparation of Rgl2 and pRB substrates, Escherichia coli transformed with pGEX-Rgl2 and pGEX-pRB (379-928) (Matsushime et al., 1994) were grown to saturation overnight, diluted 1:10 in LB broth, and incubated at 37 1C for 2 h. GST-fusion proteins were induced by incubation at 30 1C and addition of 1 mM isopropyl b-D-thiogalactopyranoside to the culture for 4 h, after which cells were recovered by centrifugation at 4 1C and lysed on ice by sonication in 1 ml of lysis buffer (50 mM HEPES pH 7.5, 150 mM NaCl, 1 mM EDTA, 1 mM DTT, 10% glycerol and 0.5% triton). Cleared lysates were mixed with glutathione-Sepharose 4B (GE Healthcare) and incubated for 2 h at 4 1C. Beads were washed three times with lysis buffer and twice with kinase buffer, and the substrate-fusion proteins were released by incubation with 2 mM reduced glutathione (Sigma). The concentration and purity of Rgl2 and pRB were estimated by Coomassie blue staining, by using protein standards.
Cell spreading assay
MEFs were co-transfected with GFP and empty expression vectors, or with GFP plus CycD1 or Rgl2-CAAX or RalBS28N expression vectors. Forty-eight hours later, cells were trypsinized and seeded in serum-free medium in a 35-mm plate coated with 10 mg/ml fibronectin (Sigma) and incubated at 37 1C in a 5% CO 2 incubator. At indicated times, Â 10 images were taken and the spread green cells were counted. Round and bright cells were considered to be unspread. Two independent experiments were done with a total of nX150 GFP cells. Confidence limits for a binomial distribution were calculated.
Cell-motility assay MEFs were co-transfected with GFP and empty expression vectors or with GFP plusand Rgl2-CAAX expression vectors. Thirty-six hours after transfection cell movement was analyzed by time-lapse microscopy. Plates were maintained in Dulbecco's modified Eagle's medium with 10% fetal bovine serum at 37 1C and 5% CO 2 , and images were taken at 5-min intervals under a Zeiss AxioObserver Z1 inverted microscope (Carl Zeiss MicroImaging, Sant Just Desvern, CAT, Spain). Cell movement velocity was determined by tracing single cells at different time points using Manual Tracking ImageJ software (Image J, http://rsbweb.nih.gov). Three independent experiments were done with a total of nX19 GFP cells. Confidence limits for a normal distribution were calculated.
Cell adhesion assay
MEFs were infected with lentiviral vectors harboring CycD1 wild-type allele, CycD1 K112E allele or Rgl2-CAAX. Fortyeight hours later, cells were trypsinized and a total of 20 000 cells were seeded in serum-free medium in a 96-well plate coated with 10 mg/ml fibronectin (Sigma). After 30 min, plates were washed two times with temperate phosphate-buffered saline, fixed and stained with crystal violet. Attached cells were represented as A590 nm.
